Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis
Status:
Completed
Trial end date:
1999-12-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES:
I. Assess the safety and efficacy of olsalazine, a dimer of 5-aminosalicylic acid, in men
with ankylosing spondylitis unresponsive to nonsteroidal anti-inflammatory drugs and
physiotherapy.